Navigation Links
Johns Hopkins receives funding for cholera vaccine initiative
Date:12/27/2012

The Johns Hopkins Bloomberg School of Public Health was awarded a four-year, $5 million grant from the Bill & Melinda Gates Foundation to promote the effective use of oral cholera vaccine around the world. The Delivering Oral Vaccine Effectively (DOVE) program will provide relief agencies and governments with technical assistance on how to use oral cholera vaccine, evaluate current vaccine-use practices and develop new field surveillance methods for monitoring and controlling outbreaks of the disease.

Cholera is an infectious disease caused by drinking unsanitary water. The disease is estimated to be responsible for between 100,000 to 200,000 deaths worldwide each year and infects as many as 2.5 million people annually. The oral cholera vaccine is over 70 percent effective and costs $1.85 per dose, but is not yet widely used in preventing outbreaks.

"We believe this grant will greatly facilitate the appropriate use of the new cholera vaccine. In partnership with the World Health Organization, UNICEF and other national and international agencies, we believe the DOVE project will provide the knowledge, technical assistance and encouragement to bring this life-saving vaccine to those who need it most," said David Sack, MD, director of DOVE and professor in the Department of International Health at the Bloomberg School.

In addition to researching and evaluating vaccine-use practices, DOVE will establish cholera surveillance in the northern region of Cameroon near Lake Chad, which appears to be a cholera hotspot. The site will help researchers develop and study methods for detecting outbreaks in remote areas and potentially for using oral vaccine to contain the disease.

The DOVE program will be part of a network of vaccine projects funded by the Gates Foundation to prevent outbreaks of cholera worldwide.


'/>"/>

Contact: Tim Parsons
tmparson@jhsph.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

Page: 1

Related medicine news :

1. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
2. A Serious Problem: Medical Malpractice Lawyers at Console & Hollawell React to Alarming Doctor Error Statistics from Johns Hopkins University Researchers
3. US Drug Watchdog Now Fears Most Women Never Heard About Yaz or Yasmin Birth Control Pill Side Effects and They Urge to Victims to Call the Johnson Law Group-Get Help Now
4. US Drug Watchdog Now Urges Any US Citizen Who Used the Diabetes Drug Called Actos and Then Developed Bladder Cancer To Contact The Johnson Law Group For A Legal Review
5. Johns Hopkins malpractice study: Surgical never events occur at least 4,000 times per year
6. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Stroke, Blood Clots, or a Heart Attack to Call the Johnson Law Group for a Legal Review
7. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
8. Johns Hopkins to aid The Leapfrog Group in grading the safety and quality of US hospitals
9. US Drug Watchdog Now Urges Family Members Of A Diabetic Who Died From Bladder Cancer After Using The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or a Heart Attack to Call the Johnson Law Group Now-Before Time Runs Out
11. Fasting may benefit patients with epilepsy, Johns Hopkins Childrens Center study suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: ... back to the presidency and to America. “Tomorrow Trump Goes To Washington” is the ... as she can for this country. , Nancy attributes her patriotic nature to her ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Fred Rides a Train” allows ... that follows. , “Fred Rides a Train” is the creation of published author, ... since her teen years in Michigan. The "Fred, the Dog" series is her first ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the fifth annual Business Architecture Innovation Summit in Reston, VA on March 21-22, ... who will share a range of experiences from a cross-section of industries such ...
(Date:12/7/2016)... ... ... NuevaCare, a leading home care agency based in San Mateo but serving ... part of its ambitious website relaunch. As Bay Area clients scramble to find quality ... their city. The new site has several key city-specific pages to address this need. ...
(Date:12/6/2016)... ... December 06, 2016 , ... People ... can be seen on a type of MRI, according to a study appearing ... of the central nervous system characterized by tremors or trembling and stiffness in ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 2016 With opioids commonly used for pain management for ... market that has led to nationwide fatalities. The synthetic ... stronger than heroin or morphine, resulting in likelihood of addiction, abuse ... , , ... clinical operations, Behavioral Health for HMC HealthWorks, explained the opioid drug ...
(Date:12/6/2016)... -- Blueprint Medicines Corporation (NASDAQ: BPMC ), a ... patients with genomically defined diseases, today announced that it ... in shares of its common stock. In addition, Blueprint ... to purchase up to an additional of $18,750,000 million ... the public offering. All shares of common stock will ...
(Date:12/6/2016)... SAN DIEGO , Dec. 6, 2016 ... focused on the development of Conditionally Active ... BioAtla and Beijing Sinobioway Group Company, Limited ... programs for development.  The specific program candidates ... In March 2015, BioAtla and Sinobioway entered ...
Breaking Medicine Technology: